Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Diheteroaryl histone deacetylase inhibitors and their use in therapy

Diheteroaryl histone deacetylase inhibitors and their use in therapy

US Patent 10407435 · Granted Sep 10, 2019

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions comprising phosphoinositide 3-kinase inhibitors and a second antipr2025
Compounds comprising tricyclic heterocyclic compounds2023
Compounds comprising tricyclic heterocyclic compounds2023
Tricyclic heterocyclic compounds as phosphoinositide 3-kinase inhibitors2023
Tricyclic heterocyclic compounds as phosphoinositide 3-kinase inhibitors2023
Method for improving the oral bioavailability of a drug2023
Compositions comprising phosphoinositide 3-kinase inhibitors and a second antipr2022
Substituted pyrazines as ATR kinase inhibitors2021
Histone deacetylase inhibitors2020
Histone deacetylase inhibitors2020
Histone deacetylase inhibitors2020
Histone deacetylase inhibitors2020